Home>>Signaling Pathways>> Ubiquitination/ Proteasome>> Autophagy>>Dynasore

Dynasore

Catalog No.GC10395

Dynasore, as a GTPase inhibitor, can rapidly and reversibly inhibit dynamin activity, which prevents endocytosis.

Products are for research use only. Not for human use. We do not sell to patients.

Dynasore Chemical Structure

Cas No.: 304448-55-3

Size Price Stock Qty
10mM (in 1mL DMSO)
$50.00
In stock
10mg
$53.00
In stock
25mg
$103.00
In stock
100mg
$302.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 3 publications

Description Protocol Chemical Properties Product Documents Related Video Related Products

Dynasore, as a GTPase inhibitor, can rapidly and reversibly inhibit dynamin activity, which prevents endocytosis[1].

Dynasore inhibits dynamin GTPase activity and transferrin uptake with IC50 of approximately 15 µM[2]. In vitro, treatment with 80 µM dynasore commonly block dynamin 1 and 2, dynasore also has a potent inhibition on ferroptosis at a range of lower concentrations. Dynasore also potently blocked H2O2-induced cell death at 100 nM[3]. In vitro experiment it demonstrated that treatment with 100 µM dynasore impairs VEGF-induced calcium release[4]. At the ocular surface of ex vivo mouse eyes, 40 uM dynasore blocked stress-stimulated dye uptake. Dynasore is obviously protective of cells and their surface glycocalyx, preventing damage due to oxidative stress, and thus precluding dye entry[5]. In vitro test it exhibited that treatment with 100 µM dynasore rapidly increased the spontaneous EPSC (sEPSC) frequency which was followed by inhibition of both solitary tract-evoked EPSCs (ST-EPSC) as well as asynchronous EPSCs[6]. In peritoneal macrophages and LLC-MK2 cells, treatment with 100 µM dynasore drastically diminished the parasite internalization[7].

In vivo efficacy test it shown that dynasore (10 mg/kg, intraperitoneally) inhibits OS tumorigenesis without inducing nephrotoxicity and hepatotoxicity[8]. In vivo, the ocular mouse Sereny model was administrated 30 mg/kg intraperitoneally did not reduce ocular inflammation, it did provide significant protection against weight loss[9].

References:

[1] Preta G, et al. Dynasore - not just a dynamin inhibitor. Cell Commun Signal. 2015 Apr 10;13:24.

[2] Lee S, et al. Synthesis of potent chemical inhibitors of dynamin GTPase. Bioorg Med Chem Lett. 2010 Aug 15;20(16):4858-64.

[3] Clemente LP, et al. Dynasore Blocks Ferroptosis through Combined Modulation of Iron Uptake and Inhibition of Mitochondrial Respiration. Cells. 2020 Oct 9;9(10):2259.

[4] Webster A, et al. Dynasore protects the ocular surface against damaging oxidative stress. PLoS One. 2018 Oct 10;13(10):e0204288.

[5] Hofmann ME, et al. Dynasore blocks evoked release while augmenting spontaneous synaptic transmission from primary visceral afferents. PLoS One. 2017 Mar 30;12(3):e0174915.

[6] Lum M, et al. Impact of dynasore an inhibitor of dynamin II on Shigella flexneri infection. PLoS One. 2013 Dec 19;8(12):e84975.

[7] Zhong B, et al. Dynasore suppresses cell proliferation, migration, and invasion and enhances the antitumor capacity of cisplatin via STAT3 pathway in osteosarcoma. Cell Death Dis. 2019 Sep 18;10(10):687.

[8] Basagiannis D, et al. Dynasore impairs VEGFR2 signalling in an endocytosis-independent manner. Sci Rep. 2017 Mar 22;7:45035.

[9] Barrias ES, et al. Dynasore, a dynamin inhibitor, inhibits Trypanosoma cruzi entry into peritoneal macrophages. PLoS One. 2010 Jan 20;5(1):e7764.

Reviews

Review for Dynasore

Average Rating: 5 ★★★★★ (Based on Reviews and 37 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Dynasore

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.